NASDAQ:IOSPInnospec Stock Price, Forecast & News

Innospec's stock was trading at $72.47 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, IOSP stock has increased by 4.5% and is now trading at $75.76. View which stocks have been most impacted by Coronavirus.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Innospec in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Innospec.

Innospec is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Innospec.

Innospec Inc. (NASDAQ:IOSP) released its quarterly earnings results on Tuesday, May, 5th. The specialty chemicals company reported $1.42 earnings per share for the quarter. The specialty chemicals company earned $372.30 million during the quarter, compared to analysts' expectations of $380 million. Innospec had a net margin of 7.79% and a return on equity of 14.77%. The business's revenue for the quarter was down 4.1% compared to the same quarter last year. During the same quarter last year, the business posted $1.25 EPS. View Innospec's earnings history.

Innospec declared a semi-annual dividend on Thursday, May 7th. Stockholders of record on Monday, May 18th will be given a dividend of $0.52 per share on Tuesday, May 26th. This represents a dividend yield of 1.5%. The ex-dividend date is Friday, May 15th. View Innospec's dividend history.

1 Wall Street analysts have issued 12-month price objectives for Innospec's stock. Their forecasts range from $95.00 to $95.00. On average, they expect Innospec's stock price to reach $95.00 in the next year. This suggests a possible upside of 25.4% from the stock's current price. View analysts' price targets for Innospec.

News stories about IOSP stock have trended negative this week, according to InfoTrie Sentiment. The research group ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Innospec earned a news impact score of -2.1 on InfoTrie's scale. They also assigned media stories about the specialty chemicals company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news about Innospec.

Innospec saw a increase in short interest during the month of June. As of June 15th, there was short interest totaling 433,000 shares, an increase of 8.8% from the May 31st total of 398,100 shares. Based on an average daily trading volume, of 129,600 shares, the short-interest ratio is presently 3.3 days. Approximately 1.8% of the company's stock are short sold. View Innospec's Current Options Chain.

Some companies that are related to Innospec include Ecolab (ECL), Sherwin-Williams (SHW), International Flavors & Fragrances (IFF), Celanese (CE), RPM International (RPM), Albemarle (ALB), NewMarket (NEU), Ashland Global (ASH), W. R. Grace & Co (GRA), Quaker Chemical (KWR), Balchem (BCPC), PolyOne (POL), HB Fuller (FUL), Sensient Technologies (SXT) and Stepan (SCL). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Innospec investors own include Altria Group (MO), NVIDIA (NVDA), Sherwin-Williams (SHW), Applied Materials (AMAT), Activision Blizzard (ATVI), Broadcom (AVGO), Boeing (BA), Caterpillar (CAT), Colgate-Palmolive (CL) and Clorox (CLX).

Innospec trades on the NASDAQ under the ticker symbol "IOSP."

Innospec's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Diversified Trust Co (0.02%). Company insiders that own Innospec stock include Brian Watt, Catherine Hessner, Hugh Aldous, Ian Cleminson, Milton C Blackmore, Patrick Williams, Philip Curran and Philip John Boon. View institutional ownership trends for Innospec.

IOSP stock was purchased by a variety of institutional investors in the last quarter, including Diversified Trust Co. View insider buying and selling activity for Innospec.

Shares of IOSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of IOSP stock can currently be purchased for approximately $75.76.

Innospec has a market capitalization of $1.86 billion and generates $1.51 billion in revenue each year. Innospec employs 2,000 workers across the globe.

The official website for Innospec is www.innospecinc.com.

Innospec's mailing address is 8310 SOUTH VALLEY HIGHWAY SUITE 350, ENGLEWOOD CO, 80112. The specialty chemicals company can be reached via phone at 303-792-5554 or via email at [email protected]